Study

EORTC-20011-HD-R2

A randomized trial of BEAM + PBSCT versus single agent high-dose therapy followed by BEAM + PBSCT in patients with relapsed Hodgkin's disease (HD-R2 protocol).

Study documentation Back to result

Trial Status

All trial activities ended

Dates

Date of activation: 17-Jul-2001
Date Step1 close: 10-Jan-2007
Date Step2 close: 06-Apr-2007

Data management at EORTC

No

Design

Phase 3
Randomized open label

Targeted Sample size

EORTC Groups: 260

Protocol summary

http://clinicaltrials.gov/study/NCT00025636

NCT number

NCT00025636